AI assistant
Orchid Pharma Limited — Call Transcript 2024
May 17, 2024
60526_rns_2024-05-17_ec61a92e-baf2-4721-a754-8e5721baa3d2.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [552 x 66] intentionally omitted <==
May 17, 2024
National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai400001 Symbol: ORCHPHARMA Scrip Code: 524372
Ref: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended
Sub : Intimation of Schedule of Analyst/ Investors Earning Call for quarter and year ended on March 31, 2024 – Orchid Pharma Limited
Dear Sir/Madam,
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and in continuation to our letter dated May 16, 2024 intimating the schedule of Board Meeting, this is to intimate that an Analysts/Investors Earning Call hosted by ‘Systematix Institutional Equities’ is schedule to be held on Friday, May 24, 2024 at 04:00 P.M. (IST) to discuss the financial performance/ financial results of the Company for quarter/ year ended on March 31, 2024.
The invite of the Investors Earning Call is enclosed herewith. The aforesaid information will also be hosted on the Company’s website at www.orchidpharma.com
Note: The schedule may undergo change due to exigencies on the part of Investors/Analysts/Company.
You are requested to take the same on record.
Thanking You, For Orchid Pharma Limited
KAPIL DAYYA Digitally signed by KAPIL DAYYA DN: c=IN, o=Person, ou=Others, postalCode=201102, l=Ghaziabad, st=Uttar Pradesh, street=238, NAIPURA LONI, GHAZIABAD LONI, title=2894, 2.5.4.20=ab829c22de1effbdfc0b22c1656149c2ef30e6aef4e71d29529c889286e22c52, serialNumber=e27acd3bad231a5f6fbc79a89feead642f7b38cfefea6c40cc3f8a9ba46b16ed, [email protected], cn=KAPIL DAYYA Date: 2024.05.17 11:59:07 +05'30' Kapil Dayya Company Secretary & Compliance Officer
Encl.: as above
==> picture [519 x 12] intentionally omitted <==
Orchid Pharma Limited Regd. Office: Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Alathur, Chengalpattu Dist.- 603110, Tamil Nadu, India Phone : (91)-44- 2744 4471/72/73 Email: [email protected] Website : www.orchidpharma.com CIN: L24222TN1992PLC022994
==> picture [261 x 45] intentionally omitted <==
SYSTEMATIX INSTITUTIONAL EQUITIES
Invites you to participate in
Q4FY24 Results Conference Call of
==> picture [127 x 42] intentionally omitted <==
Orchid Pharma Limited
On Friday, 24[th] May 2024 at 04:00 PM (IST)
The management will be represented by
Mr. Manish Dhanuka Mr. Mridul Dhanuka Mr. Sunil Kumar Gupta Managing Director Whole Time Director Chief Financial Officer
Dial-in-number
| Location Dial Number |
Location Toll Free Number |
|---|---|
| Primary Number +91 22 6280 1297 |
USA: 1 866 746 2133 |
| UK: 0 808 101 1573 |
|
| Secondary Number +91 22 7115 8198 |
Singapore: 800 101 2045 |
| Hong Kong: 800 964 448 |
Click here for your Diamond Pass™
https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=3960079&linkSecurityString=18081f8730 DiamondPass™ is a Premium Service that enables you to connect to your conference call without having to wait for an operator.
For more information, please contact:
Vishal Manchanda Mrunal Pawar
Contact No: +919737437148 [email protected]
Contact No: + 91 22 6704 8088 [email protected]